Coastal Bridge Advisors LLC Invests $490,000 in Danaher Corporation $DHR

Coastal Bridge Advisors LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR) in the second quarter, Holdings Channel.com reports. The institutional investor acquired 2,571 shares of the conglomerate’s stock, valued at approximately $490,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Sivia Capital Partners LLC boosted its holdings in Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after acquiring an additional 119 shares during the period. First Trust Advisors LP lifted its position in shares of Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after purchasing an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC grew its holdings in shares of Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after purchasing an additional 886 shares in the last quarter. Ieq Capital LLC increased its stake in Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after buying an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC increased its stake in Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after buying an additional 325 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent research reports. HSBC decreased their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Wells Fargo & Company reduced their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Guggenheim decreased their target price on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. TD Cowen lowered their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Finally, Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Danaher Price Performance

Danaher stock opened at $216.41 on Friday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The company has a fifty day simple moving average of $199.46 and a 200-day simple moving average of $192.52. The stock has a market cap of $152.13 billion, a P/E ratio of 38.44, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.77 earnings per share. Equities analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.